Investing.com -- The lawsuit filed by the U.S. Federal Trade Commission (FTC) against pharmacy benefit managers (PBMs) over insulin pricing practices is set to resume. The case had been temporarily ...

The U.S. Federal Trade Commission's lawsuit against pharmacy benefit managers (PBMs) over insulin pricing practices will ...

Chairman of the Federal Trade Commission Andrew Ferguson says he plans to resume a lawsuit alleging that the three leading ...

Federal Trade Commission Chair Andrew Ferguson has reversed course on his decision to recuse himself from the agency's legal ...

STAT reports that the administration is planning on disrupting the fentanyl supply chain in order to reduce overdose deaths. The drug policy document is not public yet. More news is on South African ...

Pharmacy benefit managers OptumRx and Express Scripts have asked the federal judge overseeing nationwide litigation over the ...

The FTC chair had previously been recused from the lawsuit. But after consulting with ethics lawyers, Ferguson changed his ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the ...

The Federal Trade Commission late Tuesday stayed a lawsuit accusing pharmacy middlemen of gaming the system to inflate the ...

The Federal Trade Commission has temporarily halted its antitrust case against several top pharmacy benefit managers including Caremark Rx, Express Scripts and Optum Rx, due to a lack of participating ...

Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair ...